A few companies are in clinicals with novel approaches to heal an initial brain injury or minimize secondary damage. Slow progress may be more related to investors’ misperceptions of the topic than ...
In this GEN webinar, our subject matter experts, Dr. Lee Fader, Dr. Jeremy Dupaul-Chicoine, and Dr. Maximilian Ebert, will provide an overview of current methodologies and technological innovations ...
Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...
By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.